Who
George Fennell
Executive Vice President
Company insider
Files Form 4 as: Executive Vice President, IDEXX Laboratories.
In numbers
- Trades disclosed
- 107
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $24.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jun 2011
- Last trade
- 1 Jun 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —639 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code F | $161K284 at $566.79 | filing |
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —639 | filing |
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —639 | filing |
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —639 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code F | $161K284 at $566.79 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —55 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —56 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —139 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —204 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —56 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —139 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —55 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —56 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —139 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX Laboratoriesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —204 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —204 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code F | $125K199 at $629.35 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —55 at $0.00 | filing |
| 14 Feb 2026filed 17 Feb 2026 | IDXX IDEXX LaboratoriesDiagnostics & Labs | SEC FORM 4 Code M | —56 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.